Anaerostipes

A genus of Gram-positive obligate anaerobes in the family Lachnospiraceae (Clostridium cluster XIVa) that occupy a critical metabolic relay position in gut ecosystem stability: converting lactate to butyrate. Anaerostipes is one of the most consistently depleted genera across inflammatory and metabolic disease states, with loss cascading into lactate accumulation, pH disruption, and pathogen expansion through mechanisms that extend into fungal immunology and neurological function.

Classification and Prevalence

Anaerostipes belongs to the Lachnospiraceae family (Clostridium cluster XIVa), closely related to Roseburia, Coprococcus, and Butyrivibrio. Two species dominate:

• A. caccae: present in ~66% of healthy adults
• A. hadrus: present in ~80% of healthy adults; the more prevalent species and primary lactate utilizer in most individuals

Both species are among the most common lactate-utilizing genera in the human gut ^[1], making Anaerostipes an essential functional node in the fermentation network.

The Lactate-to-Butyrate Relay — Core Ecological Function

The defining ecological role of Anaerostipes is the metabolic relay between primary lactate producers and the butyrate-dependent gut:

1. Lactobacillus and bifidobacterium ferment dietary carbohydrates to lactate as their primary end product.
2. Anaerostipes converts lactate to butyrate via the butyryl-CoA:acetate CoA-transferase pathway ^[1].
3. This relay simultaneously:

• Removes accumulated lactate (which at high concentrations inhibits lactate-producer growth, drops gut pH, and favors acid-tolerant pathogens)
• Produces butyrate (the primary colonocyte energy source; key anti-inflammatory signaling molecule via HDAC inhibition and GPR109a activation)

This cross-feeding relationship is mutualistic: lactate-producers benefit from lactate removal, while Anaerostipes gains an energy source that other anaerobes cannot readily utilize.

Tryptophan Metabolism — ILA Production

Beyond butyrate production, Anaerostipes contributes to the gut's tryptophan metabolite pool:

• Produces indole-3-lactic acid (ILA) from tryptophan ^[2].
• ILA is an aryl hydrocarbon receptor (AhR) ligand with anti-inflammatory properties; it modulates mucosal immunity and gut barrier integrity through AhR-ARNT signaling.
• Depleted Anaerostipes reduces ILA availability, potentially impairing AhR-mediated immune regulation alongside the more recognized SCFA deficit.
• In Graves' orbitopathy (GO), Anaerostipes is significantly downregulated alongside other Firmicutes, corresponding to decreased serum levels of IPA, ILA, and IAA ^[3]. The correlation between Anaerostipes depletion and reduced ILA levels supports the tryptophan metabolism contribution as functionally relevant.

Metal Dependencies and Heavy Metal Vulnerability

• Iron-sulfur (Fe-S) clusters in butyryl-CoA dehydrogenase are essential for the butyrate production pathway.
• Heavy metal exposure — particularly cadmium and lead — disrupts Fe-S cluster assembly and selectively depletes butyrate-producing Lachnospiraceae members ^[4].
• The selective sensitivity of Anaerostipes to metal stress (relative to acid-tolerant pathogens) means that environmental heavy metal burden can shift gut ecology away from the protective lactate-to-butyrate relay toward a pathogen-favorable, acidic, lactate-rich state.

Disease Depletion — Broad and Consistent

Anaerostipes is depleted across a remarkably broad range of diseases, always with convergent downstream consequences (lactate accumulation, butyrate deficiency):

Chronic Kidney Disease

Depleted in CKD alongside Blautia, Coprococcus, Lachnospira, and Roseburia as part of the Lachnospiraceae decline that begins at stage 3b ^[5]. Butyrate deficit contributes to uremic toxin accumulation and systemic inflammation characteristic of CKD dysbiosis.

Multiple Sclerosis

Listed among the depleted taxa in MS gut microbiome characterization, alongside Faecalibacterium and multiple Clostridia cluster IV/XIVa species ^[6]. The loss of butyrate producers in MS parallels reduced gut-brain axis regulatory capacity.

Graves' Disease Orbitopathy

Anaerostipes and Firmicutes broadly are significantly downregulated in Graves' orbitopathy patients, with corresponding decreases in serum ILA, IPA, and IAA ^[3]. This links Anaerostipes depletion to both butyrate deficiency and tryptophan metabolite depletion in the context of thyroid autoimmunity.

Autism Spectrum Disorder (Constipation-Predominant)

Anaerostipes is depleted in constipated ASD children, contributing to the broader SCFA deficit in ASD gut dysbiosis ^[7]. The lactate accumulation from Anaerostipes loss may contribute to the intestinal discomfort and constipation common in ASD.

Type 1 Diabetes

Reduced Anaerostipes is part of the broader loss of butyrate-producing Lachnospiraceae that precedes T1D onset, impacting mucosal immune regulation in the critical period of pancreatic beta cell autoimmunity.

Long COVID

Persistent Anaerostipes depletion documented in post-COVID gut microbiome studies, potentially contributing to ongoing gut barrier dysfunction and systemic inflammation in long COVID.

Schizophrenia

Butyrate-producing Lachnospiraceae are enriched in healthy controls compared to SCZ patients, with Anaerostipes among the protective taxa enriched in controls in schizophrenia microbiome profiling ^[8].

GERD — An Unexpected Risk Association

In Mendelian randomization analysis of gut microbiota and gastroesophageal reflux disease, Anaerostipes shows an increased GERD risk (OR=1.09, p=0.017) ^[9]. This counter-intuitive finding — a butyrate producer associated with increased GERD risk — may reflect the distinct immune environment of the upper GI tract where SCFA-mediated effects differ from those in the colon, or may represent reverse causation.

The Candida Connection — Lactate Accumulation and Immune Evasion

The depletion of Anaerostipes has a specific and underappreciated consequence for fungal pathogenesis:

• When lactate accumulates due to loss of lactate-utilizing bacteria, gut pH drops and the metabolic environment favors acid-tolerant organisms.
• candida albicans exploits elevated lactate to mask its beta-glucan cell wall component, evading immune recognition by Dectin-1 receptors. This beta-glucan masking is a key virulence strategy that depends on the metabolic disruption caused by Anaerostipes loss ^[1].
• The cascade: Anaerostipes depletion → lactate accumulation → Candida beta-glucan masking → Dectin-1 immune evasion → fungal overgrowth → further dysbiosis.
• This mechanism establishes Anaerostipes as an indirect gatekeeper of anti-fungal innate immunity through metabolic ecosystem maintenance.

Ecological Interactions

• Upstream: Lactobacillus, Bifidobacterium, and other lactate producers provide the substrate.
• Downstream: Butyrate produced by Anaerostipes feeds colonocytes directly and supports faecalibacterium prausnitzii through complementary fermentation.
• Disruption cascade: Loss of Anaerostipes → lactate buildup → pH drop → favors acid-tolerant Enterobacteriaceae, Candida, and other opportunists → further SCFA producer displacement → self-reinforcing dysbiosis.

What Wikipedia Doesn't Cover

Wikipedia has no Anaerostipes entry. This page provides: prevalence data for A. caccae and A. hadrus in healthy adults; the lactate-to-butyrate relay mechanism with Candida immune evasion consequences; ILA production as a tryptophan-AhR metabolism link; heavy metal vulnerability of Fe-S cluster enzymes; and the unexplained GERD risk association (an open question for the field).

Key Sources

• ^[1] — prevalence data, cross-feeding, Candida beta-glucan masking
• ^[3] — Anaerostipes depletion with ILA/IPA decrease in GO
• ^[6] — depletion in MS
• ^[5] — CKD Lachnospiraceae depletion pattern

Cross-References

• butyrate — primary product from lactate conversion
• candida albicans — enabled by lactate accumulation from Anaerostipes loss; beta-glucan masking
• bifidobacterium — upstream lactate producer in the cross-feeding chain
• lactobacillus — upstream lactate producer
• lachnospiraceae — family; shared depletion-in-disease pattern
• faecalibacterium prausnitzii — complementary butyrate producer; co-depleted in many conditions
• multiple sclerosis — depleted in MS gut microbiome
• chronic kidney disease — depleted as part of Lachnospiraceae decline from CKD stage 3b
• graves disease — depleted in GO alongside Firmicutes; ILA reduction
• autism spectrum disorder — depleted in constipation-predominant ASD
• iron — Fe-S clusters essential for butyryl-CoA dehydrogenase
• cadmium — heavy metal stress depletes butyrate-producing Lachnospiraceae
• lead — heavy metal exposure reduces SCFA-producer abundance
• dysbiosis — depletion is a convergent marker across diverse inflammatory and metabolic diseases
• short chain fatty acids — key butyrate producer via lactate relay